 		   Medrad last week announced financial results for its fiscal 1995 (end-January) that saw revenues increase9% and net earnings up as well. The Pittsburgh-based company recordedrevenues for the fiscal year of $78.3 million, compared to $71.7million in the prior year. Net earnings in 1995 will be approximately$1.15 per share, compared to 92¢ per share for the same perioda year ago.

   Medrad also announced that it has created separate businessunits for its two major businesses, vascular injection systemsand MRI surface coil products. Each unit will have its own dedicatedmanagement team and new product development functions, the companyreported.

Medrad last week announced financial results for its fiscal 1995 (end-January) that saw revenues increase9% and net earnings up as well. The Pittsburgh-based company recordedrevenues for the fiscal year of $78.3 million, compared to $71.7million in the

Medrad annual revenues up 9%